Bristol-Myers Slumps as Drug Misses Key Lung-Cancer Goal

·

·

Bristol-Myers Slumps as Drug Misses Key Lung-Cancer Goal

Bristol-Myers Squibb Co. slumped as much as 18 percent, the most in 14 years, after saying that the use of its drug Opdivo as a single agent for lung
See Original Article

Will Your Stock's Revenue Add Up The Same Under FASB 606 Accounting Rule?

The biggest change in accounting standards since the Sarbanes-Oxley Act of 2002 will shake up how public companies book revenue, in many cases
See Original Article

Pokemon Go Developer Defends App Crackdown Amid Backlash

Niantic Inc. blocked some third-party apps from accessing the servers for Pokemon Go, drawing criticism from fans and prompting a defense by the
See Original Article

U.S. Posts Another Strong Month of Job Gains

Payrolls climbed by 255,000 last month, exceeding all forecasts in a Bloomberg survey of 89 economists, following a 292,000 gain in June that was a
See Original Article

Allianz Profit Worse Than Expected on Disasters, Unit Sale

That compares with the 1.55 billion-euro average of 12 estimates compiled by Bloomberg. Allianz confirmed its target for full-year operating profit of 10
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.